FDA Inspection 1280205 — Creative Testing Solutions

Creative Testing Solutions — FEI 3000204058

The FDA completed an inspection of Creative Testing Solutions on August 29, 2025 in Tempe, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 29, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tempe, AZ (United States)

Citations

IDCFRDescription
1228821 CFR 1271.80(c)Manufacturer instructions not followed
9821 CFR 606.100(c)Thorough investigations